The phase III ICE study: Adjudiscloseant Ibandronate with or without capecitabine in elderly patients with
moderate or high risk early breast cancer
Gunter von Minckwitz, Toralf Reimer, Jochem Potenberg, Bettina Conrad, Heiko Graf, Holger Eidtmann, Marianne Just, Stephan Paepke,
Elmar Stickeler, Georg Heinrich, Michael Untch, Volker Möbus, Christoph Thomssen, Christian Jackisch, Jens Huober, Sibylle Loibl, Valentina
Nekljudova, Ulrike Nitz for the GBG / AGO-B / NOGGO / WSG study groups within the BIG framework
Gunter von Minckwitz
Estudio ICE Fase III: Ibandronato Adyuvante con o sin Capecitabina en Pacientes ancianas con cáncer de
mama temprano con riesgo moderado o alto (GBG32, BIG 4-04)
Gunter von Minckwitz, Toralf Reimer, Jochem Potenberg, Bettina Conrad, Heiko Graf, Holger Eidtmann, Marianne Just, Stephan Paepke,
Elmar Stickeler, Georg Heinrich, Michael Untch, Volker Möbus, Christoph Thomssen, Christian Jackisch, Jens Huober, Sibylle Loibl, Valentina
Nekljudova, Ulrike Nitz for the GBG / AGO-B / NOGGO / WSG study groups within the BIG framework
Dra. María del Rosario Vidal
Jefa del Servicio de Oncología Clínica del Hospital de Morón
Descargar

Estudio del Face ll IC: ibandornato adyuvante con o sin